Ozempic didn’t just disrupt weight loss.⁠ It may be creating the next major aesthetic category.⁠ ⁠ Rapid GLP-1 adoption is changing patient behaviour, treatment demand, and the long-term monetisation opportunities available to clinics.⁠ ⁠ The clinics that win won’t be the ones reacting late.⁠ They’ll be the ones positioning early.⁠ ⁠ Because in aesthetics, the biggest opportunities often come from what a trend creates next, not the trend itself.⁠ ⁠ The question is:⁠ Has your clinic recognised the shift yet?⁠ ⁠ #AestheticIndustry #ClinicGrowth #MedicalMarketing #GLP1 #Ozempic #AestheticBusiness #ClinicStrategy #Livespace